Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Håkan C. Steen"'
Autor:
Shoko Nogusa, Håkan C. Steen, Michele Y. Harris, Siddharth Balachandran, Kevin P. Kotredes, Ana M. Gamero
Publikováno v:
Journal of Cell Science.
Serine phosphorylation of STAT proteins is an important post-translational modification event that, in addition to tyrosine phosphorylation, is required for strong transcriptional activity. However, we recently showed that phosphorylation of STAT2 on
Autor:
Ana M. Gamero, Håkan C. Steen
Publikováno v:
Journal of Interferon & Cytokine Research. 32:103-110
The signal transducer and activator of transcription-2 (STAT2) was discovered as a cellular component of the DNA binding complex known as interferon (IFN) stimulated gene factor-3. Numerous studies have confirmed that STAT2 operates as a positive reg
Autor:
Ana M. Gamero, Håkan C. Steen
Publikováno v:
JAK-STAT
STAT2 is an essential transcription factor in type I IFN mediated anti-viral and anti-proliferative signaling. STAT2 function is regulated by tyrosine phosphorylation, which is the trigger for STAT-dimerization, subsequent nuclear translocation, and
Autor:
Shoko Nogusa, Amanda L. Gill, Suresh H. Basagoudanavar, Salim Merali, Roshan J. Thapa, Håkan C. Steen, Siddharth Balachandran, Carlos A. Barrero, Ana M. Gamero
Publikováno v:
The Journal of biological chemistry. 288(1)
STAT2 is a positive modulator of the transcriptional response to type I interferons (IFNs). STAT2 acquires transcriptional function by becoming tyrosine phosphorylated and imported to the nucleus following type I IFN receptor activation. Although mos
Autor:
Ana M. Gamero, Håkan C. Steen
Publikováno v:
J Interferon Cytokine Res
The discovery that type I interferon (IFN-alpha/beta) inhibited tumor cell growth was welcomed initially with great excitement as it rapidly became a U.S. Food and Drug Administration-approved drug to treat several forms of cancer. In time, this enth
Autor:
Faruk Sheikh, Ana M. Gamero, Raymond P. Donnelly, Hsiang-Wen Wang, Anthony J. Scarzello, Håkan C. Steen, Ana L. Romero-Weaver, Veronica L. Hall
Publikováno v:
Molecular cancer research : MCR. 8(1)
Type I IFNs (IFN-α/β) are pleitropic cytokines widely used in the treatment of certain malignancies, hepatitis B and C, and multiple sclerosis. IFN resistance is a challenging clinical problem to overcome. Hence, understanding the molecular mechani
Autor:
Ana M. Gamero, Håkan C. Steen
Publikováno v:
Cytokine. 48:128-129
Autor:
Håkan C. Steen, Ana M. Gamero, Roshan J. Thapa, Suresh H. Basagoudanavar, Siddharth Balachandran
Publikováno v:
Cytokine. 52:31
Autor:
Håkan C. Steen, Ana M. Gamero
Publikováno v:
Journal of Interferon & Cytokine Research; Aug2010, Vol. 30 Issue 8, p597-602, 6p